Omada Health (OMDA) CAO Craig Gracey Sells $44K of Stock
Omada Health's Chief Accounting Officer, Craig Gracey, sold shares as part of a planned transaction.
Reviewed by automated data checks against the source filing. How we make and check alerts
Craig Gracey, Chief Accounting Officer at Omada Health, Inc. ($OMDA), sold 2,083 shares at an average price of $21, worth about $43,743, on June 29, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $OMDA is up 5.5% after 1 week, down 9.5% after 1 month and down 18.6% to date (from the $21.67 close on Jun 29, 2026).
OMDA
Omada Health, Inc.
Key Points
- Craig Gracey sold 2,083 shares of Omada Health, Inc. for about $43,743 on June 29, 2026, at a price of $21.00 each.
- Omada Health's stock recently traded at $21.95, moving close to its 52-week high of $26.92, indicating strong investor interest.
- The company's outlook remains positive, with analysts giving it a 'buy' rating and a mean price target of $28.42.
Get $OMDA trade alerts by text
We text you when insiders, Congress or big funds trade $OMDA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Omada Health, Inc. alert may contain errors. Disclosures
Insider Buying and Selling at Omada Health, Inc.
Chief Accounting Officer Craig Gracey sold 2,083 shares of Omada Health, Inc. (NasdaqGS: OMDA) on June 29, 2026, for about $43,743. This transaction was planned, and Gracey received $21.00 per share.
Gracey's sale is part of a series of insider transactions at Omada Health. Just a few days before, on June 24, he sold 2,083 shares for approximately $39,598 at a price of $19.01. This suggests that insiders are actively managing their holdings, with Steven Cook, the Chief Financial Officer, also selling shares in recent weeks.
Recent Insider Activity
In the days leading up to Gracey's transaction, multiple insiders at Omada Health made significant sales. On June 26, Steven Cook sold 33,000 shares valued at about $656,370, while earlier on June 24, he sold 2,600 shares for around $49,452. Additionally, Sean Duffy, the CEO, sold 2,800 shares on the same date, which further illustrates a pattern of insider selling around this time.
How Omada Health, Inc. Stock Has Traded
Omada Health's shares recently traded at $21.95, moving close to its 52-week high of $26.92. The stock appears to be performing well, reflecting ongoing interest from investors and analysts alike. The price is above both its 50-day and 200-day moving averages, which can indicate positive momentum.
Analysts Set New Price Targets
Analysts maintain a positive outlook for Omada Health. On October 14, 2026, Freedom Capital Markets reiterated its 'Buy' rating with a price target of $35. This follows similar endorsements from other firms, including Barclays and Needham, who both provided favorable ratings with price targets ranging from $27 to $28. The consensus rating among analysts remains 'Buy', with a mean price target of $28.42.
What Omada Health, Inc. Does
Omada Health, Inc. specializes in virtual care programs, focusing on health issues like diabetes and obesity. Its services support employers and healthcare providers in managing patients remotely. As insiders continue to make trades, it shows active engagement in the company’s current market position.
What's Next for Omada Health, Inc.
Investors will be paying attention to the upcoming earnings report scheduled for November 5, 2026. Additionally, the recent insider trading activity might provide insights into how insiders view the company's performance as it prepares for this financial disclosure. Remember that these transactions reflect previous holdings and may not represent the insiders' current positions.
Related Filing Alerts
Source: Craig Gracey's Form 4 filing on $OMDA (Jun 29, 2026). Find the original filing: OMDA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts